CD4 and neoplasm: These results suggest that therapeutic IL-13Rα2 DNA prime and ECDα2 boost vaccine-induced regression of MCA304 tumor involved infiltration of CD4+ and CD8+ T cells and the production of certain chemokines in tumors.